Form 8-K - Current report:
SEC Accession No. 0001477932-25-004837
Filing Date
2025-06-30
Accepted
2025-06-27 19:51:06
Documents
14
Period of Report
2025-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K abti_8k.htm   iXBRL 8-K 60975
  Complete submission text file 0001477932-25-004837.txt   171693

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abti-20250516.xsd EX-101.SCH 5874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE abti-20250516_lab.xml EX-101.LAB 12568
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abti-20250516_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abti-20250516_pre.xml EX-101.PRE 7857
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abti-20250516_def.xml EX-101.DEF 2099
16 EXTRACTED XBRL INSTANCE DOCUMENT abti_8k_htm.xml XML 3415
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 251088454
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)